[1] O'Brien IEW, Reutingsperger CPM, Holdaway KM. AnnexinV and TUNEL use in monitoring the progression of apoptosis in plants[J]. Cytometry, 1997, 29:28-33.
[2] Ohtsuki K, Akashi K, Aoka Y, et al. Technetium-99m HYNIC-annexin V:a potential radiopharmaeeutical for the in-vivo detection of apoptosis[J]. Eur J Nucl Med, 1999,26:1251-1258.
[3] Kemerink GJ, Boersma HH, Thimister PWL et al. Biodistribution and dosimetry of 99Tcm-BTAP-annexinV[J]. Eur J Nucl Med, 2001, 28:1373-1378.
[4] Kobayashi H, Yoo TM, Sim IS, et al. L-lysine effectively blocks renal uptake of 125I or Tc-labeled anti-Tac disulfidestabilized Fr fragment[J]. Cancer Res, 1996, 56:3788-3795.
[5] Puig M, Ballester M, Matias-Guiu X, et al. Burden of myocardial damage in cardiac allograft rejection:scintigraphic evidence of myocardial injury and histological evidence of myocyte necrosis and apoptosis[J]. J Nucl Cardiol, 2000, 7(2):132-139.
[6] Narula J, Acio ER, Narula N, et al. AnnexinV imaging for noninvasive detection of cardiac allograft rejection[J]. J Nat Med, 2001,7(12):1347-1352.
[7] Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death[J]. Michael J Abrams, 1998, 95:6349-6354.
[8] Yaoita H, Ogawa K, Maehara K, et al. Attenuation ofischemia/reperfusion injury in rats by a caspase inhibitor[J]. Circula-tion, 1998, 97:276-281.
[9] Hofstra L, Liem IH, Dumont EA, et al. Visualization of cell death in vivo in patients with acute myocardial infarction[J]. Lancet, 2000, 356(9225):209-212.
[10] Goussev A, Sharov VG, Shimoyama H, et al. Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure[J]. Am J Physiol, 1998, 275:626-631.
[11] Kown MH, Blankenberg FG, Hoyt G, et al. Zinc-mediated reduction of apoptosis in cardiac allografts[J]. Circulation,2000,102(19 suppl 3):Ⅲ228-232.